Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines April 18, 2014

Business: Lockheed to Lose 17 F-35s Under Automatic Pentagon Cuts - Pentagon will cut 17 of the 343 F-35 fighters it planned to buy from Lockheed Martin in fiscal 2016 through 2019 unless Congress repeals automatic budget cuts, according to a new Defense Department report. DOD looking for ways not to break MH-60R helo deal - The...
 
 

News Briefs April 18, 2013

U.S. military deaths in Afghanistan at 2,177 As of April 15, 2014, at least 2,177 members of the U.S. military had died in Afghanistan as a result of the U.S.-led invasion of Afghanistan in late 2001, according to an Associated Press count. At least 1,802 military service members have died in Afghanistan as a result...
 
 
LM-F35-hours

F-35 fleet surpasses 15,000 flying hours

The Lockheed Martin F-35 Lightning II fleet recently surpassed 15,000 flight hours, marking a major milestone for the program.  “Flying 15,000 hours itself demonstrates that the program is maturing, but what I think is e...
 

 
nasa-cassini

NASA Cassini images may reveal birth of new Saturn moon

NASA’s Cassini spacecraft has documented the formation of a small icy object within the rings of Saturn that may be a new moon, and may also provide clues to the formation of the planet’s known moons. Images taken w...
 
 

NASA completes LADEE mission with planned impact on Moon’s surface

Ground controllers at NASA’s Ames Research Center in Moffett Field, Calif., have confirmed that NASA’s Lunar Atmosphere and Dust Environment Explorer spacecraft impacted the surface of the moon, as planned, between 9:30 and 10:22 p.m., PDT, April 17. LADEE lacked fuel to maintain a long-term lunar orbit or continue science operations and was intentionally sent...
 
 
Photograph courtesy of NASA Ames/SETI Institute/JPL-Caltech

NASA’s Kepler telescope discovers first Earth-size planet in ‘habitable zone’

Photograph courtesy of NASA Ames/SETI Institute/JPL-Caltech Kepler-186f resides in the Kepler-186 system about 500 light-years from Earth in the constellation Cygnus. The system is also home to four inner planets, seen lined up...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>